Phase II, open-label study of erdafitinib in adult and adolescent patients (pts) with advanced solid tumours harboring fibroblast growth factor receptor (FGFR) gene alterations

Authors :: Schuler, Martin
Tabernero, J.
Massard, C.
Iyer, G. Vasudeva
Witt, Olaf
Doi, T.
Qin, S.
Lu-Emerson, C.
Hargrave, D.
Garcia-Corbacho, J.
Little, S.
Xia, Q.
Santiago-Walker, A.
Moy, C.H.
Hammond, C.
Lau, Y.Y.
Sweiti, H.
Pant, S.
Publication Year :: 2020

Tools